Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H24N2O3 |
| Molecular Weight | 280.3627 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCNC(=O)COC1=CC=C(OC)C=C1
InChI
InChIKey=HUNIPYLVUPMFCZ-UHFFFAOYSA-N
InChI=1S/C15H24N2O3/c1-4-17(5-2)11-10-16-15(18)12-20-14-8-6-13(19-3)7-9-14/h6-9H,4-5,10-12H2,1-3H3,(H,16,18)
| Molecular Formula | C15H24N2O3 |
| Molecular Weight | 280.3627 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Further study and the comparative characteristics of potential stimulants of higher nervous activity]. | 1982-09-01 |
|
| Mefexamide as an antiparkinson drug. (A double-blind study). | 1969-04 |
|
| [Clinical trial with a new antidepressive and anti-asthenia drug; Mefexamide]. | 1967-04-05 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:01 GMT 2025
by
admin
on
Mon Mar 31 18:16:01 GMT 2025
|
| Record UNII |
84FP054Z2Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081460
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
C100080
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
SUB08708MIG
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
3769
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
1227-61-8
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
757827
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
4045
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
214-963-1
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
1637
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
84FP054Z2Q
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
DTXSID5048475
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL1368380
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
Mefexamide
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | |||
|
m811
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
C175123
Created by
admin on Mon Mar 31 18:16:01 GMT 2025 , Edited by admin on Mon Mar 31 18:16:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |